See All Slides - tctmd.com

Slides

Presentation TCT 2012

STACCATO Revisited: Reflections and Take-home Messages

Presenter: Leif Thuesen

October 22, 2012

Presentation TCT 2012

Plasmonic Photothermal Therapy of Atherosclerotic Lesions with Silica-Gold Nanoparticles

Presenter: Alexander Kharlamov

October 22, 2012

Presentation TCT 2012

SUPPORT-1: A Prospective, Randomized Trial of a Lipoic Acid-Based Cytoprotectant in Patients Undergoing Elective PCI

Presenter: Mitchell Krucoff

October 22, 2012

Presentation TCT 2012

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

Presenter: Rudiger Lange

October 22, 2012

Presentation TCT 2012

An Overview of TAVR Complications from a Meta-analysis Using VARC Definitions

Presenter: Philippe Genereux

October 22, 2012

Presentation TCT 2012

Step 6: Clinical Regulatory Pathways

Presenter: Semih Oktay

October 22, 2012

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

$Mobilized CD 34+ Cells for Refractory Angina$

Presentation TCT 2012

Mobilized CD 34+ Cells for Refractory Angina

Presenter: Thomas Povsic

October 22, 2012

Presentation TCT 2012

TCT-106: BioInnovate Ireland: A Multidisciplinary Approach To Medical Device Innovation

Presenter: Mark Bruzzi

October 22, 2012

Presentation TCT 2012

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

Presenter: Anupam Bhambhani

October 22, 2012

Advertisement

Slides

STACCATO Revisited: Reflections and Take-home Messages

Plasmonic Photothermal Therapy of Atherosclerotic Lesions with Silica-Gold Nanoparticles

SUPPORT-1: A Prospective, Randomized Trial of a Lipoic Acid-Based Cytoprotectant in Patients Undergoing Elective PCI

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

An Overview of TAVR Complications from a Meta-analysis Using VARC Definitions

Step 6: Clinical Regulatory Pathways

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Mobilized CD 34+ Cells for Refractory Angina

TCT-106: BioInnovate Ireland: A Multidisciplinary Approach To Medical Device Innovation

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content